Recombinant CoV-2 Spike E-Mosaic Antigen, His-tagged

Specification

• Cat#: VAC-0303
• Product Name: Recombinant CoV-2 Spike E-Mosaic Antigen, His-tagged
• Description: The E. coli derived recombinant protein contains the Coronavirus 2019 spike Envelope Mosaic immunodominant regions having a Mw of 40.5 kDa, fused to 6 × His tag at C-terminal.
• Species: CoV-2
• Molecular Weight: 40.5 kDa
• Source: Escherichia Coli.
• Introduction: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019.The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.
• Purity: CoV 2019 Spike E-Mosaic Protein is >90% pure as determined SDS-PAGE.
• Stability: CoV 2019 Spike E-Mosaic Protein is shipped on ice packs. Upon arrival, Store at -20°C.
• Usage: All the products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.